Pleurodynia Treatment Market: Current Analysis and Forecast (2023-2030)
$3999 – $6999
Emphasis on Diagnosis (Blood test, Culture test, X-ray); Treatment (Analgesics or Painkillers, Immunoglobulin); Mode of Administration (Oral, Injections, or infusion); End-Users (Hospitals, Pharmacy, Others) and Region/Country
Pages: | 173 |
---|---|
Table: | 82 |
Figure: | 106 |
Report ID: | UMHE212058 |
Geography: |
Report Description
The Pleurodynia treatment market was valued at USD 191 million in 2022 & is expected to grow at a CAGR of 5% from 2023-2030 Pleurodynia, also known as Bornholm disease, is a viral infection that affects the intercostal muscles, which are the muscles between the ribs. It is characterized by sudden-onset severe chest pain that can be quite intense and may also cause fever and other flu-like symptoms. Pleurodynia is commonly caused by enteroviruses, such as Coxsackieviruses. The growing demand for pleurodynia treatments can be attributed to the increase in the reliance of people on painkillers around the globe. Furthermore, the pleurodynia treatment market is anticipated to grow on account of Increased awareness and improved diagnostic capabilities could lead to more accurate and timely diagnoses of pleurodynia. Moreover, Advances in medical technology and innovations in drug delivery systems or diagnostic tools may facilitate the development and delivery of more effective and targeted treatments for pleurodynia has led to a growing demand for pleurodynia treatments. For instance, in 2021, Novartis, a leading global pharmaceutical company, announced promising results in its research for antiviral therapies. The company’s commitment to developing novel antiviral drugs could pave the way for potential treatments for various viral infections, including pleurodynia. However, some of the restraints in the market including the high development costs and variable disease severity are impeding the growth of this market all over the world.
Some of the major players operating in the market include Eli Lilly, Bayer AG, Reckitt Benckiser plc, Bristol-Myers Squibb, Novartis, F. Hoffmann-La Roche Ltd, Teva Pharmaceutical Industries Ltd., Endo Pharmaceuticals, Pfizer Inc., Merck. Several M&As along with partnerships have been undertaken by these players to facilitate customers with hi-tech and innovative products/technologies.
Insights Presented in the Report
“Amongst diagnosis, the blood test segment held a significant share of the market in 2022.”
Based on the diagnosis, the market is segmented into blood test, culture test, and X-ray. Among them, the PVDF segment captured a significant share of the market in 2021. Advancements in blood test technologies and the identification of specific biomarkers associated with pleurodynia may enhance the accuracy of diagnosing the condition. This can lead to more efficient and precise diagnosis, facilitating timely treatment
“Amongst treatment, the analgesics or painkillers segment held the higher CAGR in the market in 2022.”
Based on the treatment, the market is bifurcated into analgesics or painkillers and immunoglobulin. Among them, the analgesics or painkillers segment is expected to grow at a higher CAGR in the market. Pleurodynia is characterized by severe chest pain that can be debilitating for patients. Analgesics or painkillers are commonly used to provide symptomatic relief and alleviate pain, making them an essential component of the treatment regimen for pleurodynia.
Pleurodynia treatment Market Report Coverage
“North America dominated the Pleurodynia treatment market in 2022.”
North America, particularly the United States, is a hub for biotechnology and pharmaceutical research. In North America, including the United States and Canada, there has been a growing emphasis on rare diseases and orphan drugs. Pleurodynia, being a relatively rare condition, falls into this category. Governments, regulatory agencies, and healthcare organizations have recognized the need to address unmet medical needs for rare diseases and incentivize research and development of treatments. For instance, in 2020, Moderna Inc., a biotechnology company based in the United States, gained significant attention for its groundbreaking mRNA-based COVID-19 vaccine, which was authorized for emergency use during the COVID-19 pandemic. The success and prominence of Moderna in the field of mRNA-based vaccines have been instrumental in highlighting the potential of mRNA technology for various medical conditions, including rare diseases. Moreover, Advancements in medical technology have the potential to impact the treatment of various medical conditions, including pleurodynia. In the North America region, where healthcare infrastructure and funding for research are relatively robust, the adoption of cutting-edge technologies can lead to improved diagnostics, better monitoring of patients, and the development of innovative treatment options.
Reasons to buy this report:
- The study includes market sizing and forecasting analysis validated by authenticated key industry experts.
- The report presents a quick review of overall industry performance at one glance.
- The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolios, expansion strategies, and recent developments.
- Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry.
- The study comprehensively covers the market across different segments.
- Deep dive regional level analysis of the industry.
Customization Options:
The global Pleurodynia treatment market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.
You can also purchase parts of this report. Do you want to check out a section wise
price list?
Research Methodology
Research Methodology for the Pleurodynia treatment Market Analysis (2023-2030)
Analyzing the historical market, estimating the current market, and forecasting the future market of the global Pleurodynia treatment market were the three major steps undertaken to create and analyze the adoption of Pleurodynia treatment in major regions globally. Exhaustive secondary research was conducted to collect the historical market numbers and estimate the current market size. Secondly, to validate these insights, numerous findings and assumptions were taken into consideration. Moreover, exhaustive primary interviews were also conducted, with industry experts across the value chain of the global Pleurodynia treatment market. Post assumption and validation of market numbers through primary interviews, we employed a top-down/bottom-up approach to forecasting the complete market size. Thereafter, market breakdown and data triangulation methods were adopted to estimate and analyze the market size of segments and sub-segments of the industry pertains to. Detailed methodology is explained below:
Analysis of Historical Market Size
Step 1: In-Depth Study of Secondary Sources:
Detail secondary study was conducted to obtain the historical market size of the Pleurodynia treatment market through company internal sources such as annual reports & financial statements, performance presentations, press releases, etc., and external sources including journals, news & articles, government publications, competitor publications, sector reports, third-party database, and other credible publications.
Step 2: Market Segmentation:
After obtaining the historical market size of the Pleurodynia treatment market, we conducted a detailed secondary analysis to gather historical market insights and share for different segments & sub-segments for major regions. Major segments are included in the report as diagnosis, treatment, mode of administration, and end-user. Further country-level analyses were conducted to evaluate the overall adoption of testing models in that region.
Step 3: Factor Analysis:
After acquiring the historical market size of different segments and sub-segments, we conducted a detailed factor analysis to estimate the current market size of the Pleurodynia treatment market. Further, we conducted factor analysis using dependent and independent variables such as diagnosis, treatment, mode of administration, and end-user of the pleurodynia treatment market. A thorough analysis was conducted for demand and supply-side scenarios considering top partnerships, mergers and acquisitions, business expansion, and product launches in the Pleurodynia treatment market sector across the globe.
Current Market Size Estimate & Forecast
Current Market Sizing: Based on actionable insights from the above 3 steps, we arrived at the current market size, key players in the global Pleurodynia treatment market, and market shares of the segments. All the required percentage shares split, and market breakdowns were determined using the above-mentioned secondary approach and were verified through primary interviews.
Estimation & Forecasting: For market estimation and forecast, weights were assigned to different factors including drivers & trends, restraints, and opportunities available for the stakeholders. After analyzing these factors, relevant forecasting techniques i.e., the top-down/bottom-up approach were applied to arrive at the market forecast for 2030 for different segments and sub-segments across the major markets globally. The research methodology adopted to estimate the market size encompasses:
- The industry’s market size, in terms of revenue (USD) and the adoption rate of the Pleurodynia treatment market across the major markets domestically
- All percentage shares, splits, and breakdowns of market segments and sub-segments
- Key players in the global Pleurodynia treatment market in terms of products offered. Also, the growth strategies adopted by these players to compete in the fast-growing market.
Market Size and Share Validation
Primary Research: In-depth interviews were conducted with the Key Opinion Leaders (KOLs) including Top Level Executives (CXO/VPs, Sales Head, Marketing Head, Operational Head, Regional Head, Country Head, etc.) across major regions. Primary research findings were then summarized, and statistical analysis was performed to prove the stated hypothesis. Inputs from primary research were consolidated with secondary findings, hence turning information into actionable insights.
Split of Primary Participants in Different Regions
Market Engineering
The data triangulation technique was employed to complete the overall market estimation and to arrive at precise statistical numbers for each segment and sub-segment of the global pleurodynia treatment market. data was split into several segments & sub-segments post studying various parameters and trends in the areas of the diagnosis, treatment, mode of administration, and end-user in the global Pleurodynia treatment market.
The main objective of the Global Pleurodynia treatment Market Study
The current & future market trends of the global Pleurodynia treatment market were pinpointed in the study. Investors can gain strategic insights to base their discretion for investments on the qualitative and quantitative analysis performed in the study. Current and future market trends determined the overall attractiveness of the market at a regional level, providing a platform for the industrial participant to exploit the untapped market to benefit from a first-mover advantage. Other quantitative goals of the studies include:
- Analyze the current and forecast market size of the Pleurodynia treatment market in terms of value (USD). Also, analyze the current and forecast market size of different segments and sub-segments
- Segments in the study include areas of the diagnosis, treatment, mode of administration, and end-user
- Define and analysis of the regulatory framework for the Pleurodynia treatment industry
- Analyze the value chain involved with the presence of various intermediaries, along with analyzing customer and competitor behaviors of the industry
- Analyze the current and forecast market size of the Pleurodynia treatment market for the major region
- Major countries of regions studied in the report include Asia Pacific, Europe, North America, and the Rest of the World
- Company profiles of the Pleurodynia treatment market and the growth strategies adopted by the market players to sustain in the fast-growing market
- Deep dive regional level analysis of the industry
You can also purchase parts of this report. Do you want to check out a section wise
price list?
You must be logged in to post a review.
Reviews
There are no reviews yet.